 | Up a level |
Rayson, D.; Suter, T. M.; Jackisch, C.; Van Der Vegt, S.; Bermejo, B.; Van Den Bosch, J.; Vivanco, G. L.; Van Gent, A. M.; Wildiers, H.; Torres, A.; Provencher, L.; Temizkan, M.; Chirgwin, J.; Canon, J. L.; Ferrandina, G.; Srinivasan, S.; Zhang, L.; Richel, D. J. (2012). Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial. Annals of oncology, 23(7), pp. 1780-1788. Oxford University Press 10.1093/annonc/mdr519
Rayson, D.; Richel, D.; Chia, S.; Jackisch, C.; Van Der Vegt, S.; Suter, T. (2008). Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies. Annals of oncology, 19(9), pp. 1530-1539. Oxford University Press 10.1093/annonc/mdn292
